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Summary
 
The B cell antigen receptor (BCR) consists of the membrane-bound immunoglobulin (Ig)
molecule as antigen-binding subunit and the Ig-
 
a
 
/Ig-
 
b
 
 heterodimer as signaling subunit. BCR
signal transduction involves activation of protein tyrosine kinases (PTKs) and phosphorylation
of several proteins, only some of which have been identified. The phosphorylation of these
proteins can be induced by exposure of B cells either to antigen or to the tyrosine phosphatase
inhibitor pervanadate/H
 
2
 
O
 
2
 
. One of the earliest substrates in B cells is a 65-kD protein, which
we identify here as a B cell adaptor protein. This protein, named SLP-65, is part of a signaling
complex involving Grb-2 and Vav and shows homology to SLP-76, a signaling element of the
T cell receptor. In pervanadate/H
 
2
 
O
 
2
 
-stimulated cells, SLP-65 becomes phosphorylated only
upon expression of the BCR. These data suggest that SLP-65 is part of a BCR transducer
complex.
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E
 
ngagement of the B cell antigen receptor (BCR)
 
1
 
 trig-
gers the phosphorylation of proteins on tyrosine and
the concomitant activation of a variety of signaling path-
ways. The tyrosine phosphorylation of phospholipase C-
 
g
 
leads to hydrolysis of phosphoinositides which produces
second messengers able to elevate intracellular [Ca
 
2
 
1
 
] and ac-
tivate protein kinase C (1–3). The BCR-mediated activation
of the ras/Raf/Map kinase pathway is less well understood
but is likely to involve p120rasGAP and the Grb-2–Sos com-
plex (1–3). Tyrosine-phosphorylated Vav exhibits GDP/
GTP exchange activity for Rac-1, a small G protein impli-
cated in cell proliferation and cytoskeletal organization (4).
The activation of these and other signaling cascades is not
restricted to BCR-stimulated B cells, and some signaling
elements are used by many receptors. The stimulated BCR
must both maintain signal specificity and avoid interference
with other types of receptor that are not stimulated. A pre-
formed BCR transducer complex would make this possible
by allowing the rapid and selective activation of BCR-spe-
cific signaling pathways, even in those cases where some
signaling elements are common to the BCR and another
receptor. The analysis of substrate phosphorylation in
J558L B cells treated with pervanadate/H
 
2
 
O
 
2
 
 suggests that
as soon as it is expressed, the BCR indeed recruits and or-
ganizes intracellular signaling elements into a signaling
complex (5). The existence of preformed signaling complexes
has been directly demonstrated for the photoreceptor sys-
tem in drosophila (6) and for the osmoadaptation–phero-
mone response system in yeast (7). In both cases, specific
adaptor proteins were found to organize the physical and
functional coupling of intracellular signaling proteins to re-
ceptors in the plasma membrane. We have tried to identify
protein tyrosine kinase (PTK) substrate proteins that be-
come tyrosine phosphorylated early after BCR stimulation.
Here we report on the identification and cloning of such a
protein, which we named SLP-65 (Src homology [SH2]
domain–containing leukocyte protein of 65 kD). This B
cell–specific adaptor protein contains a number of protein–
protein interaction domains and is constitutively associated
with Grb-2 and Vav. In the absence of a BCR, treatment
of the cells with pervanadate/H
 
2
 
O
 
2
 
 does not induce phos-
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell antigen receptor; GST, glu-
tathione 
 
S
 
-transferase; HA, hemagglutinin; ORF, open reading frame;
PTK, protein tyrosine kinase; RACE, rapid amplification of cDNA ends;
SH2 and SH3 domain, Src homology 2 and 3 domain, respectively; SLP-
65, SH2 domain–containing leukocyte protein of 65 kD.
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phorylation of SLP-65. Our results suggest a scaffolding
function for SLP-65 which would couple BCR activation
to intracellular signaling pathways.
 
Materials and Methods
 
Materials.
 
Immobilized PT66 antiphosphotyrosine-agarose
beads (Sigma-Aldrich, Deisenhofen, Germany) and soluble 4G10
antiphosphotyrosine antibodies (Upstate Biotechnology Inc.,
Lake Placid, NY) were used for precipitation and immunoblot
analysis of phosphotyrosine-containing proteins, respectively.
Anti-Vav and anti–Grb-2 rabbit polyclonal antibodies were pur-
chased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA).
Polyclonal anti–SLP-65 antibodies were produced by immuniz-
ing rabbits with KLH-coupled SLP-65 peptides encompassing
amino acids 148–161 (KARLA peptide; see Fig. 1). The glu-
tathione 
 
S
 
-transferase (GST)–Grb-2 fusion proteins contain
amino acids 1–168 (SH3-SH2) and 49–168 (SH2) of the human
Grb-2 protein, respectively. Primer sequences used for amplifica-
tions of the respective Grb-2 cDNA fragments are available upon
request. The plasmid encoding the GST–Grb-2 (SH3) fusion
protein was a gift of Dr. William Wishart, Novartis (Basel, Swit-
zerland). The GST fusion protein encompassing the complete
murine Grb-2 was obtained from Upstate Biotechnology Inc.
 
Protein Analysis.
 
J558L cell lines, pervanadate/H
 
2
 
O
 
2
 
 stimula-
tions, immunoprecipitations, affinity purifications with GST fu-
sion proteins, and Western blot analysis were described previously
(5, 8).
 
Large-scale Preparation and Amino Acid Sequencing of PTK Sub-
strate Proteins.
 
In total, 10
 
10
 
 J558L
 
d
 
m7.1 cells were stimulated in
aliquots of 3 
 
3
 
 10
 
7
 
 cells per ml RPMI 1640 medium for 3 min
with 50 
 
m
 
M pervanadate/H
 
2
 
O
 
2
 
 at 37
 
8
 
C (5). After lysis of the cells
in 600 
 
m
 
l of 1% NP-40 lysis buffer (5), postnuclear supernatants
were collected and precleared for 3 h with 7.5 ml of mouse IgG
agarose (Sigma-Aldrich). Subsequently, the lysate was subjected
to antiphosphotyrosine immunoprecipitation with 6 ml of aga-
rose-conjugated PT66 mAb (Sigma-Aldrich). Settled beads were
extensively washed with 1% NP-40 lysis buffer, and bound pro-
teins were eluted eight times with 7.5 ml 50 mM phenyl phos-
phate/200 mM NaCl. Proteins were concentrated with centrifu-
gal filter devices (microsep 10K; Pall Filtron Corp., East Hills,
NY), separated by 10% SDS-PAGE, and stained with Coomassie
blue. The 65-kD protein band was excised, subjected to in-gel
digestion with lysyl endopeptidase C (Lys-C), and the resulting
HPLC-purified peptides were sequenced (TOPLAB, Munich,
Germany; see Fig. 1).
 
cDNA Isolation.
 
Several independent clones of a 2-kb cDNA
(GenBank accession no. Y17159) were isolated using a combina-
tion of standard PCR with primers derived from a partial cDNA
sequence in GenBank (accession no. AJ222814) and 5
 
9
 
 rapid am-
plification of cDNA ends (5
 
9
 
RACE; GIBCO BRL, Gaithers-
burg, MD) and completely sequenced.
 
Northern Blot Analysis.
 
As described previously (9), total cel-
lular RNA was isolated, and 15 
 
m
 
g per sample was separated in a
denaturing agarose gel. After blotting, hybridization was per-
formed with a randomly primed 795-bp PstI fragment from nu-
cleotide 650 to 1445 (the open reading frame [ORF] extends
from 478 to 1851).
 
Transient Protein Expression.
 
For transient expression of SLP-65
in J558L
 
m
 
m3 cells, a 1490-bp PCR fragment (amplified with
PfuI [Stratagene Inc., La Jolla, CA]) containing the entire ORF
was cloned downstream of the CMV promoter in pCGN (10).
The resulting expression vector, pCGN-p65, encodes a SLP-65
fusion protein containing an NH
 
2
 
-terminal, 20 amino acid pep-
tide tag which is derived from the hemagglutinin protein of hu-
man influenza virus (HA tag [11]). The conditions for electropo-
ration have been described previously (9).
 
Results and Discussion
 
To identify PTK substrate proteins in B cells, we affinity
purified these proteins from the lysate of pervanadate/
H
 
2
 
O
 
2
 
-stimulated J558L
 
d
 
m7.1 cells via antiphosphotyrosine
antibody columns and determined their peptide sequence.
We focused on a 65-kD protein which is the most rapidly
phosphorylated substrate after exposure of J558L
 
d
 
m7.1
cells to antigen or to pervanadate. Several of the sequenced
peptides matched with a partial sequence in GenBank (ac-
cession no. AJ222814). Using mouse splenic cDNA as tem-
plate, we used a combination of conventional and 5
 
9
 
RACE
PCR to isolate 
 
z
 
2 kb of the corresponding cDNA (acces-
sion no. Y17159). The cDNA we obtained has an ORF
encoding a protein of 457 amino acids (Fig. 1 
 
A
 
). Seven of
the peptides sequenced from the purified protein were
found in the predicted sequence (Fig. 1 
 
A
 
, 
 
underline
 
). The
NH
 
2
 
-terminal portion of the protein contains seven ty-
rosine residues which are putative targets for phosphoryla-
tion (Fig. 1 
 
A
 
, 
 
dots
 
). Five of these are found in a YxxP con-
text otherwise found in the PTK substrates Cas, p62dok,
Cbl, and SLP-76 (12–15). The central part of the protein is
Figure 1. The SLP-65 gene encodes a protein with several regions of
similarity to SLP-76 and is transcribed in lymphoid tissues. (A) Deduced
amino acid sequence of murine SLP-65. Dots, Potential tyrosine-phos-
phorylation sites are marked. Box, The COOH-terminal SH2 domain.
Underline, Peptide sequences obtained from affinity-purified SLP-65. (B)
SLP-65 transcripts of z2 kb were detected by Northern blot analysis of
RNA from the indicated tissues and cell lines. The SLP-65 probe used
was derived from the ORF, and a reference signal for ribosomal 28S
RNA was used as a loading control. (C) Anti–SLP-65 precipitates were
prepared from postnuclear supernatants of pervanadate/H2O2-stimulated
J558Lmm3 cells, transiently transfected either with the parental vector
(lane 1) or an expression vector encoding SLP-65 with an NH2-terminal
HA tag (lane 2). Precipitated proteins were analyzed by antiphosphoty-
rosine (anti-pY) immunoblotting. 
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rich in prolines and contains several SH3 domain–binding
motifs. The COOH-terminal part contains an SH2 domain
which, when compared with the database, is most similar
to the SH2 domain of SLP-76, a recently identified PTK
substrate in T lymphocytes (15). Both proteins share the
same overall structure. A comparison with human and
mouse SLP-76 also reveals a modest similarity in the NH
 
2
 
terminus (not shown). We conclude that the 65-kD pro-
tein substrate is the B cell analogue of SLP-76, and call it
SLP-65. In a Northern blot analysis, the 2-kb SLP-65 tran-
script is found only in spleen and weakly in thymus, but
not in liver, testis, or brain (Fig. 1 
 
B
 
). The transcript is also
found in B cell lines representing different developmental
stages from the pre-B to the plasma cell stage, but not in a
T cell or a fibroblast line (Fig. 1 
 
B
 
). These results suggest
that SLP-65 is primarily expressed in B lymphocytes but
perhaps to some extent also in thymocytes.
SLP-65 has a predicted pI of 8.2, in good agreement
with our experimental data showing a pI of 8.5 (data not
shown). The predicted molecular mass of 50.7 kD is con-
siderably smaller than the apparent size of 65 kD in SDS-
PAGE. To test whether this could be due to aberrant
migration, and to obtain further evidence that we had in-
deed isolated the cDNA encoding the tyrosine-phosphory-
lated 65-kD substrate, we transiently expressed SLP-65 in
J558L
 
m
 
m3 cells as a fusion protein with an NH
 
2
 
-terminal
HA tag (see Materials and Methods). Anti–SLP-65 peptide
antibodies (see Materials and Methods) precipitated the
HA-tagged fusion protein from pervanadate/H
 
2
 
O
 
2
 
-stimu-
lated J558L
 
m
 
m3 transfectants but not from control cells.
The HA-tagged SLP-65 migrates slightly above the endog-
enous SLP-65 as detected by antiphosphotyrosine antibod-
ies (Fig. 1 
 
C
 
) and anti-HA antibodies (data not shown). We
conclude that the cDNA we isolated encodes the 65-kD
substrate for activated PTKs.
In T cells, the SLP-76 adaptor protein is bound by Grb-2
and Vav (16–18). Anti–SLP-65 antibodies, but not the
preimmune serum, coprecipitate Grb-2 and Vav from ly-
sates of unstimulated and pervanadate/H
 
2
 
O
 
2
 
-stimulated
J588L
 
m
 
m3 cells (Fig. 2, lanes 
 
2
 
 and
 
 4
 
). The phosphorylated
form of SLP-65 is only found in the lysates of pervanadate/
H
 
2
 
O
 
2
 
-stimulated cells (Fig. 2, 
 
top
 
, lane 
 
4
 
). These data show
that SLP-65 is constitutively associated with Grb-2 and
Vav, supporting the notion that SLP-65 is the B cell ana-
logue of SLP-76. Using different GST–Grb-2 fusion pro-
teins, SLP-65 could be purified from lysates of unstimu-
lated and pervanadate/H
 
2
 
O
 
2
 
-stimulated J558L
 
m
 
m3 cells
with the NH
 
2
 
-terminal SH3 domain of Grb-2 (Fig. 3, 
 
bot-
tom
 
, lanes 
 
1
 
 and 
 
2
 
) and to an even stronger extent with the
combined SH3 and SH2 domains (Fig. 3, lanes 
 
3
 
 and 
 
4
 
).
SLP-65 bound only weakly to the SH2 domain of Grb-2
and not at all to GST alone (Fig. 3, lanes 
 
5
 
, 
 
6
 
, 
 
9
 
, and 
 
10
 
).
Probing the same blot with antiphosphotyrosine antibodies
showed that, in addition to SLP-65, the Grb-2 SH3 do-
main coprecipitates a phosphoprotein of 110 kD. This pro-
tein may be identical or similar to the SLP-76–associated
protein SLAP130/FYB (19, 20). These proteins, as well as
other phosphoproteins, were more efficiently purified by
the combination of the SH3 and SH2 domains of Grb-2 but
not by GST alone (lanes 
 
4 and 10). Two proteins with
characteristics similar to SLP-65 have been also found in a
human B cell line (21).
We have previously shown that after exposure to per-
vanadate, a 65-kD protein is rapidly phosphorylated only in
BCR-positive cells (5). To verify that SLP-65 is iden-
tical to this early PTK substrate, we stimulated the BCR-
negative J558L line and its BCR-positive transfectant
J558Lmm3 for different times with pervanadate/H2O2.
Similar amounts of SLP-65 were purified from these cells
with the GST–Grb-2[SH3-SH2] fusion protein (Fig. 4, bot-
Figure 2. SLP-65 is constitutively
associated with Vav and Grb-2.
J558Lmm3 cells were left unstimu-
lated (lanes 1 and 2) or stimulated for
2 min with 50 mM pervanadate/
H2O2 (lanes 3 and 4). Cleared cellular
lysates were subjected to immuno-
precipitation with preimmune serum
(pre-i., lanes 1 and 3) or anti–SLP-65
antibodies (lanes 2 and 4). Tyrosine-
phosphorylated SLP-65 was detected
by antiphosphotyrosine immunoblot-
ting (anti-pY, top). The Vav and Grb-2
proteins were detected by probing
the same filter with anti-Vav (middle)
and anti–Grb-2 antibodies (bottom).
Figure 3. The NH2-terminal
SH3 domain of Grb-2 is sufficient
to bind SLP-65. Grb2-binding
proteins were purified from ly-
sates of unstimulated (lanes 1, 3,
5, and 7) and pervanadate/H2O2-
stimulated J558Lmm3 cells (lanes
2, 4, 6, and 8) using GST fusion
proteins containing different do-
mains of Grb-2: NH2-terminal
SH3 domain (lanes 1 and 2),
NH2-terminal SH3 plus SH2 do-
main (lanes 3 and 4), SH2 domain
(lanes  5 and 6), and complete
Grb-2 (lanes 7 and 8). GST was
used as a control (lanes 9 and 10). Proteins were detected by antiphosphoty-
rosine and anti–SLP-65 immunoblotting (top and bottom, respectively).
Figure 4. Tyrosine phosphoryla-
tion of SLP-65 is dependent on BCR
expression. BCR-negative J558L
cells (lanes 1–3) and BCR-positive
J558Lmm3 cells (lanes 4–6) were un-
stimulated (lanes 1 and 4) or stimu-
lated with 25 mM pervanadate/H2O2
either for 10 s (lanes 2 and 5) or 2
min (lanes 3 and 6). Proteins com-
plexed with GST–Grb-2[SH3-SH2]
fusion proteins were detected by anti-
phosphotyrosine and anti–SLP-65
immunoblotting (top and bottom, re-
spectively).794 Characterization and Cloning of SLP-65
tom, lanes 1–6). However, the SLP-65 protein remained
completely unphosphorylated in the BCR-negative line,
even after 2 min of stimulation (Fig. 4, top, lane 3). In the
BCR-positive transfectant, SLP-65 is rapidly phosphory-
lated, 10 s after stimulation (lane 5). Other PTK substrate
proteins in the BCR-negative and -positive lines require
longer times of stimulation for detection with antiphospho-
tyrosine antibodies (Fig. 4, top, lanes 3 and 6). Thus, the
rapid phosphorylation of SLP-65 in J558Lmm3 B cells is
dependent on the BCR surface expression.
Our data suggest that SLP-65 is part of a BCR trans-
ducer complex comprising not only kinases, phosphatases,
and their substrates, but also adaptor proteins which are
necessary to physically and functionally connect these ele-
ments. This may be a common theme in signal transduc-
tion (6, 7). The early and BCR-dependent phosphoryla-
tion of SLP-65, together with its restricted expression
pattern, suggest that SLP-65 is critically involved in cou-
pling intracellular signaling elements specifically to the
BCR. This may contribute to a basal level of signaling in
the absence of antigen, a mechanism that may be necessary
for B cell maintenance (22, 23). Such a central role in signal
transduction is also suggested for SLP-76. Overexpression
of SLP-76 in T cells can augment signal transduction from
the TCR, leading to increased nuclear factor of activated T
cells (NFAT) activation and IL-2 secretion (24, 25). Fur-
thermore, mice deficient for SLP-76 contained no periph-
eral T cells as a result of an early block in T cell develop-
ment, whereas B cells develop normally (26). To better
understand the function of the SLP protein family, it will
be necessary to reveal exactly how they are connected to
the antigen receptors.
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